CAPN13 p.Arg144Pro
c.431G>C · rs374775173 · VCV3137079
Computational evidence
| Protein change | ||
| AlphaMissense | 0.9428 | likely pathogenic · top 1% in CAPN13 |
|---|---|---|
| REVEL | 0.258 | benign-leaning |
| SaProt | LLR -12.06 | damaging |
| ⇒ AlphaMissense and SaProt call this damaging; REVEL does not. | ||
| Splicing | ||
| SpliceAI | Δ0.33 | acceptor loss · deltas |
| Constraint at this position | ||
| Conservation | phyloP 0.097 | GERP -2.9, phastCons 0.22 |
| Regional constraint | o/e 1.05 | unconstrained · MANE · 57 kb · p 0.12 · regional, not allelic |
| Overall | ||
| CADD | 21.6 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| African / African-Americangrpmax | 0.0347% | 2,882 |
| European (non-Finnish) | 0.00017% | 589,939 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CAPN13
- Protein
- p.Arg144Pro
- Coding
- c.431G>C
- MANE Select
- NM_144575
- dbSNP
- rs374775173
- Type
- single nucleotide variant
- Location
- chr2:30770406 (GRCh38)
- Gene constraint
- LOEUF 1.121 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 83.25 · 1 PDB
- Residue 144
- the calpain catalytic domain
Similar variants
- CAPN13 p.Arg144Cys Uncertain significance ★ ⚠ same residue
- CAPN13 p.Arg144His Uncertain significance ★ ⚠ same residue
- CAPN13 p.Ala172Ser Uncertain significance ★ ⚠ same type
- CAPN13 p.Ala215Ser Uncertain significance ★ ⚠ same type
- CAPN13 p.Ala2Val Uncertain significance ★ ⚠ same type
- CAPN13 p.Ala326Val Uncertain significance ★ ⚠ same type
- CAPN13 p.Ala460Gly Uncertain significance ★ ⚠ same type
- CAPN13 p.Ala510Pro Uncertain significance ★ ⚠ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/capn13-p-arg144pro (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown